DZ Bank Reiterates “Neutral” Rating for AXA (CS)

AXA (EPA:CS)‘s stock had its “neutral” rating reissued by equities research analysts at DZ Bank in a report released on Thursday.

A number of other research analysts also recently commented on the company. Citigroup set a €26.20 ($31.19) price objective on AXA and gave the stock a “neutral” rating in a research note on Friday, September 8th. Deutsche Bank set a €28.50 ($33.93) price objective on AXA and gave the stock a “buy” rating in a research note on Wednesday, November 22nd. Kepler Capital Markets set a €29.80 ($35.48) price objective on AXA and gave the stock a “buy” rating in a research note on Friday, November 3rd. Barclays set a €26.00 ($30.95) price objective on AXA and gave the stock a “buy” rating in a research note on Friday, September 8th. Finally, JPMorgan Chase & Co. set a €28.80 ($34.29) price objective on AXA and gave the stock a “buy” rating in a research note on Thursday, October 12th. Eight analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of €27.24 ($32.43).

AXA (CS) opened at €24.74 ($29.45) on Thursday. The company has a market capitalization of $59,940.00 and a price-to-earnings ratio of 10.53. AXA has a 52 week low of €21.81 ($25.96) and a 52 week high of €26.34 ($31.36).

ILLEGAL ACTIVITY WARNING: “DZ Bank Reiterates “Neutral” Rating for AXA (CS)” was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://weekherald.com/2017/12/30/dz-bank-reiterates-neutral-rating-for-axa-cs.html.

About AXA

AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply